MENU
XBIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Xenetic Biosciences (XBIO) Ownership - Who owns Xenetic Biosciences?
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
945 Concord Street
Phone
+1 781 778-7720
Employees
4
Web
https://www.xeneticbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.16M
P/E Ratio
N/A
Total Cash
6.84M
Projected Growth
N/A
Total Debt
152.53K
Revenue
2.52M
Risk (Beta)
2.43
Dividend Yield
N/A
Total Cash/Share
4.44
Total Debt/Equity
N/A
Revenue/Share
1.62 USD as % of share price
Fundamentals
XBIO
Capitalization
4.16M
P/E Ratio
N/A
Risk (Beta)
2.43
Dividend Yield
N/A
Total Cash
6.84M
Total Cash/Share
4.44
Total Debt
153K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.62%
Revenue
2.52M
ROE
N/A
Book Value
7.04M
P/B Ratio
0.69
Cash Flow
N/A
Earnings
-2.66
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.55K
Current Ratio
6.96
Current Revenue Per Employee
153560.75
Dividends Per Share - Security
N/A
EBITDA
-4.36M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-40.76
Shares Held By Institutions
371K
Shares Outstanding - Current
1.54M
Total Liabilities
1.01M
Total Volume MTD
N/A
Value
1
Gain YTD
-32.456
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biologic drugs, novel oncology therapeutics, and vaccinations
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
945 Concord Street
Phone
+1 781 778-7720
Employees
4
Web
https://www.xeneticbio.com